Develop suitable drug formulations for the lead compounds, considering factors like solubility, stability, and route of administration.
If you need to purchase chemical raw materials, submit your demand information to get the latest quotations.
(1RS)-2-(4''-methoxy-4'-phenoxybenzenesulfonyl)-1,2,3,4-tetrahydro-norarmano-1-carboxylic acid
C18H19NOS2
4-nitro-3-(3-bromophenylamino)pyridine N-oxide
N-(3-chlorobenzyl)-N-methylpiperidin-4-amine
methyl 3-(4-((2-chloropyridin-4-yl)ethynyl)phenyl)propanoate
2’-(4-nitrophenoxycarbonyl)paclitaxel
(2R)-2-bromo-4-methylpentanoic acid t-butyl ester
4-BroMo-5,7-diMethyl-2,3-dihydro-1H-inden-1-one
methyl 1-(4-chlorobenzyl)-1H-pyrrole-2-carboxylate
C23H17N5O
N,N'-(6H,12H-5,11-methanodibenzo[b,f][1,5]diazocine-2,8-diyldi-2,1-ethanediyl)-bis[N-(2-methoxycarbonylethyl)phenethylamine]
ethyl 5-(4-(4-fluorobenzamido)phenyl)isoxazole-3-carboxylate
HCl
N-[4-(imidazo[1,2-b]pyridazin-6-yloxy)phenyl]-N'-phenylurea
2-(acetyloxy)-N,N-dimethyl-N-[(trimethylsilyl)methyl]ethanaminium iodide
Choline
Propanedioic acid, methyl-, monoethyl ester, potassium salt
N1-(7-chloroquinolin-4-yl)-N2-{2-[(dimethylamino)methyl]benzyl}ethan-1,2-diamine
4,6-DICHLORO-1-METHYL- 1H-PYRAZOLO[3,4-B]PYRIDINE
UREA